* Ultralife Corp ULBI.OQ ULBI.O is expected to show a
rise in
quarterly revenue when it reports results on February 1
(estimated).
* The Newark New York New York-based company is expected to
report a 55.7% increase in revenue to $37 million from $23.76
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Ultralife Corp is
for
earnings of 9 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ultralife
Corp is
$12, above its last closing price of $3.99.
This summary was machine generated January 30 at 14:12 GMT. All
figures in US dollars unless otherwise stated